Cipla Foundation has announced its partnership with the Indian Institute of Science (IISc) to support the establishment of a state-of-the-art Cipla Foundation Centre for Pulmonary Medicine at the Tata IISc Medical School in Bengaluru.
The Centre will offer diagnostics, outpatient and inpatient services, a dedicated ICU, and high-dependency units to deliver cutting-edge treatment for respiratory illnesses.
The Centre for Pulmonary Medicine will strengthen India’s respiratory health ecosystem through early diagnosis and advanced research, as well as skill development. It will support the development of India-specific guidelines for Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease (ILD), and asthma, alongside research in biomarkers, pharmacogenomics, AI-based lung diagnostics, and therapeutics. The Centre will also train pulmonologists and allied specialists, promote knowledge-sharing through workshops and global collaborations, and drive community programs on early screening, air quality awareness, smoking cessation, and preventive lung health.
India continues to carry a significant burden of respiratory illnesses, including COPD and asthma, making lung health an important public health focus. Factors such as rising air pollution, tobacco use, occupational exposure, and limited awareness contribute to this challenge. At the same time, the availability of trained pulmonologists and specialised care facilities remains uneven, particularly outside of major cities, affecting timely access to quality respiratory care.
